Chief Justice dumps stock so he can hear vax case

Chief Justice John Roberts has sold all his Pfizer stock, in part so he can participate in a case that will determine if vaccine makers are guarded against certain liability suits by the federal vaccine injury law. Story

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.